Medically reviewed by Shahrzad Shadmani, PMHNP-BC, FNP-C, founder of Integrative Psychiatry and Wellness (IPW Health).
Published September 16, 2026.
For a week or two every month, you are not recognisable to yourself.
You go from steady to spiralling. From patient to furious over something that would not have registered ten days ago. From hopeful to certain that nothing will get better. You say things you would not say. You cancel plans. You lie awake convinced your relationships are ending.
Then your period starts, and within a day or two it lifts. You look back at what you thought and said and feel ashamed of a version of yourself you can no longer quite access — until the next cycle, when she comes back.
That pattern is not weakness, and it is not random. It’s the defining feature of a diagnosis.
PMDD is a psychiatric diagnosis, not a description
Premenstrual dysphoric disorder appears in the American Psychiatric Association’s DSM-5-TR as a depressive disorder. It is not a stronger way of saying PMS, and it is not a wellness term.
Diagnosis requires a specific pattern. In most cycles over the past year, at least five symptoms are present in the final week before menses, begin to improve within a few days after menses starts, and are minimal or absent in the week after menses ends. At least one of those symptoms must be a core mood symptom: marked mood swings or emotional sensitivity, marked irritability or anger, marked depressed mood or hopelessness, or marked anxiety and tension.
The remaining symptoms can include reduced interest in usual activities, difficulty concentrating, low energy, changes in appetite, sleeping too much or too little, a sense of being overwhelmed or out of control, and physical symptoms such as breast tenderness, bloating, or joint and muscle pain.
Two further requirements do real work. The symptoms must cause significant interference with work, school, relationships or daily functioning — not merely be unpleasant. And they must not simply be the premenstrual worsening of another condition, such as depression, an anxiety disorder, or a personality disorder, though PMDD can occur alongside any of them.
The timing is the diagnosis
PMDD lives in the luteal phase — the stretch between ovulation and the start of your period. Symptoms build in that window and remit shortly after bleeding begins.
That timing is not a detail. It is the thing that distinguishes PMDD from every other mood condition. A depression that happens to be worse some weeks is not PMDD. A mood pattern that continues through the follicular phase is not PMDD, however severe it is.
This is also why so many people are treated for years for something else first. The cyclical pattern is invisible in a single appointment, and it’s genuinely hard to see from memory.
Why you have to track it prospectively
PMDD cannot be reliably diagnosed from what you remember.
DSM-5-TR requires confirmation by prospective daily ratings across at least two symptomatic cycles. Before that, the diagnosis is provisional. Retrospective recall — even honest, careful recall — consistently fails to match what daily tracking shows. Some people who are certain their symptoms are premenstrual turn out to have symptoms throughout the cycle; others discover a pattern far sharper than they realised.
In practice this means rating a short list of mood, physical and functional symptoms once a day for two cycles, including the days you feel fine — those are the ones that establish the contrast. Validated instruments exist for this, and a clinician can give you one.
It is worth the two months. It converts a story that is easy to dismiss into a record that is hard to argue with.
What’s actually happening: sensitivity, not abnormal hormones
This is the part most articles get wrong, so it’s worth being precise.
People with PMDD do not, as a rule, have abnormal hormone levels. Studies comparing estrogen and progesterone levels in people with and without PMDD have generally not found the differences you would expect if the problem were too much or too little of something. Measuring your hormones will usually come back normal — and a normal result does not mean nothing is wrong with you.
The prevailing model is differential sensitivity: the hormonal fluctuations of a normal cycle are the same, but the central nervous system responds to them differently. Research in this area has focused particularly on progesterone’s metabolite allopregnanolone, which acts on GABA-A receptors — part of the brain’s inhibitory, calming signalling — and on interactions with serotonin. Experimental work in which the hormonal cycle is suppressed and hormones then reintroduced has supported the idea that the change in hormone levels, rather than the level itself, provokes symptoms in susceptible people.
The mechanism is not fully settled, and you should be sceptical of anyone who describes it as though it were. What is reasonably well established is the shape of it: normal hormonal change, atypical neural response.
How common is it, and how serious
PMDD affects a meaningful minority of menstruating people. Prevalence estimates vary considerably depending on whether the diagnosis was confirmed by prospective daily ratings — studies that require confirmation report substantially lower figures than those relying on questionnaires alone.
Severity matters more than prevalence here. Research consistently finds elevated rates of suicidal thoughts and suicide attempts among people with PMDD, and the risk concentrates in the luteal phase. If your premenstrual week includes thoughts of not wanting to be alive, that is not something to track quietly for two cycles before mentioning. Tell a clinician now, and use the crisis line below if you need it today.
What treatment looks like
Treatment for PMDD is well established, and most people improve. These are described at the level of approach — what’s appropriate for you is a clinical decision.
SSRIs. Serotonergic antidepressants are first-line for PMDD in major guidance, including from the American College of Obstetricians and Gynecologists, and several carry FDA approval for this indication. What’s distinctive is that they can work differently here than in depression: response is often rapid rather than taking weeks, and three dosing strategies are recognised — continuous dosing through the cycle, luteal-phase dosing during the symptomatic window only, and dosing started at symptom onset. Which strategy fits depends on your pattern, your cycle regularity and how you tolerate the medication. That’s a conversation with a prescriber, not something to work out from an article.
Hormonal approaches. Combined oral contraceptives are used to suppress ovulation and flatten the cyclical change; at least one formulation has FDA approval for PMDD. They don’t help everyone, and some people feel worse on them. For severe symptoms that don’t respond to anything else, ovulation suppression with GnRH agonists plus add-back therapy is used in specialist settings.
Therapy and lifestyle. Cognitive behavioural therapy has evidence in PMDD, particularly for coping with the luteal window and its aftermath. Regular exercise, protected sleep, and limiting alcohol during the symptomatic phase help many people, and they are reasonable to start while you track. They are supportive measures, not a treatment plan on their own for a condition this disabling.
When to get evaluated
If your life is reliably disrupted for one to two weeks of every month — your work, your relationships, your sense of who you are — that is enough reason to be evaluated. You do not have to prove it first.
Start the daily tracking now, because it makes the first appointment far more productive. But don’t wait two months to make the appointment.
IPW Health provides psychiatric evaluation and medication management by telehealth in California, Oregon, Washington and Colorado, and in person in Mission Viejo, California. We can set up prospective daily symptom tracking with you, which is the step that confirms the diagnosis. If you are trying to work out whether what you experience is PMS or PMDD, we cover that comparison in a separate article.
This article is general education, not medical advice, and reading it does not create a patient–provider relationship. Treatment decisions depend on your history and should be made with a clinician who knows it.
If you are in crisis or having thoughts of harming yourself, call or text 988 to reach the Suicide and Crisis Lifeline, available 24 hours a day in the United States. If you are in immediate danger, call 911.
Sources
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR).
- American College of Obstetricians and Gynecologists. Premenstrual Syndrome and Premenstrual Dysphoric Disorder (clinical guidance).
- National Institute of Mental Health. Premenstrual Dysphoric Disorder / women’s mental health materials.
- Office on Women’s Health, U.S. Department of Health and Human Services. Premenstrual Dysphoric Disorder (PMDD).
- International Association for Premenstrual Disorders (IAPMD) — patient tracking tools and diagnostic guidance.
